Skip to main content
. Author manuscript; available in PMC: 2015 Aug 28.
Published in final edited form as: J Acquir Immune Defic Syndr. 2013 Apr 15;62(5):e146–e152. doi: 10.1097/QAI.0b013e3182840d4e

TABLE 3.

Association Between Clinic Characteristics and Attrition

Early Follow-Up (≤6 Months)
Late Follow-Up (>6 Months)
No. Events Rate (Per 100 Person-Years) Attrition, aHR* (95% CI) P No. Events Rate (Per 100 Person-Years) Attrition, aHR* (95% CI) P
Clinic model
    Vertical 1488 57.70 1.00 (ref) 0.87 431 15.13 1.00 (ref) 0.03
    Integrated 1226 55.37 0.97 (0.71 to 1.33) 430 21.83 1.75 (1.04 to 2.94)
Clinic location
    Rural 996 60.02 1.00 (ref) 0.30 401 23.02 1.00 (ref) 0.02
    Urban 1721 58.83 0.84 (0.61 to 1.17) 459 14.94 0.57 (0.35 to 0.91)
Clinic experience
    First 6 months 150 76.00 1.00 (ref) 0.08
    Post first 6 months 2558 55.79 0.71 (0.49 to 1.04)

Early attrition—fFirst 6 months of patient follow-up; late attrition—post first 6 months of patient follow-up.

*

Adjusted for pre-ART CD4 count, WHO stage, age, education, and pharmacy staff burden; CD4 count, education, and pharmacy staff burden allowed to have time time-varying effects in early/late follow-up.